Deliver Your News to the World

Pharmaceutical Information Exchange Established


WEBWIRE

IBC Life Sciences Launches Pharmaceutical Development Series

WESTBOROUGH, MA -- 12/14/2004 -- According to PharmaProjects, an unrivalled source of business-critical competitor and global R&D intelligence, the top 10 pharmaceutical companies in 2003 spent close to $36 billion in research and development. Companies are spending more on R&D than ever before - yet the number of new drug approvals has declined steadily. Clearly, the largest challenge facing drug developers is to contain R&D costs, keep pace with new technology and reduce development times without compromising clinical test design.

To help fuse an information exchange that moves research and development forward, IBC Life Sciences is pleased to announce its Pharmaceutical Development Series. This conference series centers on topics within Phase I to Phase IV clinical trials, which include drug development, drug delivery, regulatory affairs and business/outsourcing strategy.

Six new conferences will debut in spring 2005, providing a community learning experience for scientific and supporting industries connected by the emerging challenges and issues in pharmaceutical development. The dedicated pharmaceutical development professionals presenting at these events will discuss their experiences and discoveries while offering insight regarding industry advancements, technologies and trends impacting clinical trial progress.

“With increasing competition in pharmaceutical development, more emphasis is being placed on ways to improve the assessment of compounds and improve the efficiency and success rate of clinical development,” said Jim Wagner, president, IBC Life Sciences. “We’ve developed the Pharmaceutical Development Series a result of thorough research and the outreach of our sister publishing and database products such as Scrip, Drug and Market Development, Good Clinical Practice Journal and PharmaProjects. The series will offer high-value information in unique formats designed around the concept that people must walk away from an event with information that will improve their job performance, and an honest evaluation of technologies, which can change their process or contacts to expand their business. No organization today is better poised to serve this global market than us.”

Through the Pharmaceutical Development Series, IBC delivers events designed to stimulate discussion, examine new technology, and explore new research methodologies to improve clinical trial results. The upcoming spring conferences include:

Adaptive Designs for Clinical Development
http://www.ibclifesciences.com/3059
January 24-25, 2005 * Boston, MA

Regulatory Submission Standards
http://www.ibclifesciences.com/3113
April 4-5, 2005 * Reston, VA

Cost and Contract Management
lharriman@ibcusa.com
May 16-17, 2005 * Boston, MA

Drug Delivery World
mpower@ibcusa.com
May 16-18, 2005 * La Jolla, CA

Pediatric Clinical Trials
mpower@ibcusa.com
June 2-3, 2005 * Philadelphia, PA

Portfolio Management
plevine@ibcusa.com
June 2005 * Location TBD

For more than 25 years, IBC has been producing conferences for the biotech/pharmaceutical industry. IBC Life Sciences is part of T&F Informa, a media conglomerate that delivers highly relevant information through life science products. Specific products include: SCRIP World Pharmaceutical News, GCPj, SCRIP’s Target Drug Delivery, Pharmaprojects, Scrip’s Pharmaceutical Company Fact File, RAJ, ERA News, Clinica, D&MD, BioProcess International.



WebWireID624





This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.